Label: KILLA ACNE EXTRA STRENGTH- salicylic acid patch

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated June 16, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients

    Salicylic Acid 2%

  • Purpose

    Acne Treatment

  • Ask a doctor

    If irritation becomes severe

  • When using this product

    Skin irritation and dryness may occur if you use another topical acne medication at the same time or immediately following. If irritation occurs, only use one topical acne medication at a time unless directed by a doctor.

  • Keep out of reach of children

    If swallowed, get medical help or contact a Posion Control Center right away.

  • NA

    NA

  • Warnings

    For extrernal use only

  • Inactive Ingredients

    Inactive Ingredients:

    Sodium Hyaluronate, Phytosphingosine HCL, Niacinamide, Oligopeptide-10, Glycolic Acid, Madecassoside, 4-Butylresorcinol.

    Patch: Hydrocolloid

  • Uses

    Uses:

    • For the management of acne.
    • Penetrates pores to eliminate most blemishes
  • Killa Acne ES PDP

    KAES 4 Pack PDP

  • INGREDIENTS AND APPEARANCE
    KILLA ACNE EXTRA STRENGTH 
    salicylic acid patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81746-420
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.0125 mg  in 0.6216 mg
    Inactive Ingredients
    Ingredient NameStrength
    OLIGOPEPTIDE-10 (UNII: Q46328TRNK)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    GLYCOLIC ACID (UNII: 0WT12SX38S)  
    4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    MADECASSOSIDE (UNII: CQ2F5O6YIY)  
    PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:81746-420-013220 mg in 1 BOX; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)05/26/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalM00601/01/2023
    Labeler - Zitsticka, Inc. (117778611)
    Establishment
    NameAddressID/FEIBusiness Operations
    Raphas695914964manufacture(81746-420)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!